In this Section |
256546 Mortality in Children with End Stage Renal Disease and Kidney TransplantationTuesday, October 30, 2012
Objectives. This study investigated the risk of mortality for children receiving kidney transplantation. Methods. From the Taiwan National Health Insurance claims data of 1998-2009, we identified children with hemodialysis (HD) and periodontal dialysis (PD) and later receiving kidney transplantation . Mortality rates in children with kidney transplantation were compared by baseline dialysis status and comorbidity before the transplantation. Results. The transplantation rates were similar between children receiving HD (86/393, 21.8%) and PD (46/219, 21.0%). Both groups of patients were more prevalent with hypertension (67.2% vs. 66.2%, respectively) and infection (45.0% vs. 47.0%, respectively) than with diabetes (4.58% vs. 0.46%, respectively). The mortality rate in children with kidney transplantation was 1.98-fold greater in the PD group than in the HD group (5.08 vs. 2.56 per 100 person-years) with the Cox model measured HR of 1.58 (95% CI 1.19 = 2.08) after controlling for demographic factors and comorbidity. Patients with hypertension and infection were at higher risk of mortality. Conclusion. Among children with kidney transplantation, those in the PD group are at a higher mortality risk than those in the HD group. Hypertension and infection may also contribute to the mortality risk.
Learning Areas:
Clinical medicine applied in public healthLearning Objectives: Keywords: Children and Adolescents, Treatment Outcomes
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: Qualified on the content I am responsible for because: I have been the principal or co-principal of multiple federally funded grants focusing on the epidemiology of mortality in children with end stage renal disease and kidney transplantation. Among my scientific interests has been the development of strategies for quality of dialysis in children. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 4361.0: Poster Session: Maternal & Child Health
|